Dr. De Vente is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1043 Elm Ave
Suite 302
Long Beach, CA 90813Phone+1 562-247-7740
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1994 - 1996- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1991 - 1994
Vanderbilt University School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 2000 - 2025
OH State Medical License 1993 - 1998
Publications & Presentations
PubMed
- 148 citationsCabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1...David A. Margolis, Cynthia Brinson, Graham H R Smith, Jerome De Vente, Debbie Hagins
The Lancet. Infectious Diseases. 2015-10-01 - 12 citationsLong-acting cabotegravir and rilpivirine for maintenance of HIV-1 suppression: pOLAR month 12 results.Anthony M. Mills, Gary Richmond, Cheryl L. Newman, Olayemi Osiyemi, Jerry Cade
AIDS. 2021-10-13 - 2 citationsLong-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study.Kenneth C Sutton, Jerome De Vente, Roger Leblanc, Edwin Dejesus, Graham Smith
Open Forum Infectious Diseases. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
